| Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav Z Songyang, SE Shoelson, J McGlade, P Olivier, T Pawson, XR Bustelo, ... Molecular and cellular biology 14 (4), 2777-2785, 1994 | 1188 | 1994 |
| S. typhimurium encodes an activator of Rho GTPases that induces membrane ruffling and nuclear responses in host cells WD Hardt, LM Chen, KE Schuebel, XR Bustelo, JE Galán Cell 93 (5), 815-826, 1998 | 1078 | 1998 |
| Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product P Crespo, KE Schuebel, AA Ostrom, JS Gutkind, XR Bustelo Nature 385 (6612), 169-172, 1997 | 978 | 1997 |
| GTP‐binding proteins of the Rho/Rac family: regulation, effectors and functions in vivo XR Bustelo, V Sauzeau, IM Berenjeno Bioessays 29 (4), 356-370, 2007 | 905 | 2007 |
| Regulatory and signaling properties of the Vav family XR Bustelo Molecular and cellular biology 20 (5), 1461-1477, 2000 | 648 | 2000 |
| Analysis of receptor signaling pathways by mass spectrometry: identification of vav-2 as a substrate of the epidermal and platelet-derived growth factor receptors A Pandey, AV Podtelejnikov, B Blagoev, XR Bustelo, M Mann, HF Lodish Proceedings of the National Academy of Sciences 97 (1), 179-184, 2000 | 550 | 2000 |
| Product of vav proto-oncogene defines a new class of tyrosine protein kinase substrates XR Bustelo, JA Ledbetter, M Barbacid Nature 356 (6364), 68-71, 1992 | 365 | 1992 |
| Biological and regulatory properties of Vav-3, a new member of the Vav family of oncoproteins N Movilla, XR Bustelo Molecular and cellular biology 19 (11), 7870-7885, 1999 | 330 | 1999 |
| Phosphorylation‐dependent and constitutive activation of Rho proteins by wild‐type and oncogenic Vav‐2 KE Schuebel, N Movilla, JL Rosa, XR Bustelo The EMBO journal, 1998 | 320 | 1998 |
| Vav proteins, adaptors and cell signaling XR Bustelo Oncogene 20 (44), 6372-6381, 2001 | 265 | 2001 |
| Azathioprine suppresses ezrin-radixin-moesin-dependent T cell-APC conjugation through inhibition of Vav guanosine exchange activity on Rac proteins D Poppe, I Tiede, G Fritz, C Becker, B Bartsch, S Wirtz, D Strand, ... The Journal of Immunology 176 (1), 640-651, 2006 | 249 | 2006 |
| Tyrosine phosphorylation of the vav proto-oncogene product in activated B cells XR Bustelo, M Barbacid Science 256 (5060), 1196-1199, 1992 | 249 | 1992 |
| Rac-1 dependent stimulation of the JNK/SAPK signaling pathway by Vav. P Crespo, XR Bustelo, DS Aaronson, OA Coso, M López Barahona, ... Oncogene, 1996 | 220 | 1996 |
| Tyrosine phosphorylation mediates both activation and downmodulation of the biological activity of Vav M López-Lago, H Lee, C Cruz, N Movilla, XR Bustelo Molecular and cellular biology 20 (5), 1678-1691, 2000 | 213 | 2000 |
| Rac1 function is required for Src-induced transformation: evidence of a role for Tiam1 and Vav2 in Rac activation by Src JM Servitja, MJ Marinissen, A Sodhi, XR Bustelo, JS Gutkind Journal of Biological Chemistry 278 (36), 34339-34346, 2003 | 206 | 2003 |
| The Vav–Rac1 pathway in cytotoxic lymphocytes regulates the generation of cell-mediated killing DD Billadeau, KM Brumbaugh, CJ Dick, RA Schoon, XR Bustelo, ... The Journal of experimental medicine 188 (3), 549-559, 1998 | 205 | 1998 |
| The 90S preribosome is a multimodular structure that is assembled through a hierarchical mechanism J Pérez-Fernández, A Román, J De Las Rivas, XR Bustelo, M Dosil Molecular and cellular biology 27 (15), 5414-5429, 2007 | 204 | 2007 |
| T cell receptor internalization from the immunological synapse is mediated by TC21 and RhoG GTPase-dependent phagocytosis N Martínez-Martín, E Fernández-Arenas, S Cemerski, P Delgado, ... Immunity 35 (2), 208-222, 2011 | 199 | 2011 |
| Rac1 mediates STAT3 activation by autocrine IL-6 TR Faruqi, D Gomez, XR Bustelo, D Bar-Sagi, NC Reich Proceedings of the National Academy of Sciences 98 (16), 9014-9019, 2001 | 186 | 2001 |
| Isolation and characterization of murine vav2, a member of the vav family of proto-oncogenes. KE Schuebel, XR Bustelo, DA Nielsen, BJ Song, M Barbacid, D Goldman, ... Oncogene 13 (2), 363-371, 1996 | 182 | 1996 |
